Concepedia

Rhys Jones

RJ

30

Publications

1.7K

Citations

23

H-Index

1982

Active since

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

University Hospital of Wales

University of Maryland, Baltimore

Purdue University West Lafayette

Rhys Jones is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1982–2024

30

Publications

30

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 284 citations · Full text

Smoking and Anesthesia

A. C. Pearce, Rhys Jones · Anesthesiology · 1984 · 160 citations · Full text

, , +16

Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · 2020 · 158 citations · Full text

Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer

Kevin D. Freeman‐Cook, Robert L. Hoffman, Douglas C. Behenna et al. · Journal of Medicinal Chemistry · 2021 · 112 citations · Full text

Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses

Ben Forbes, Raegan O’Lone, Philippa Pribul Allen et al. · Advanced Drug Delivery Reviews · 2014 · 90 citations · Full text

, , +15

Rows per page

1–5 of 30